Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02921256
Title Veliparib and Combination Chemotherapy in Treating Patient With Locally Advanced Rectal Cancer
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors National Cancer Institute (NCI)
Indications

rectum adenocarcinoma

Therapies

Veliparib

Fluorouracil + Leucovorin + Oxaliplatin + Pembrolizumab

Capecitabine + Veliparib

Capecitabine

Age Groups: adult | senior
Covered Countries USA


No variant requirements are available.